Trial intelligence / Profile preview

Bupivacaine vs Ropivacaine for Sciatic Block Duration

NCT01272921Phase 4Completed

Sponsor
Northwestern University
Start
Nov 2010
Primary completion
Aug 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Bupivacaine with Ropivacaine (2 arms). Primary endpoint: Duration of Motor and Sensory Block of the Sciatic Nerve at 3 days. Started Nov 2010; status: completed.

02

Drugs

bupivacaineropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01272921.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01272921.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call